Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.


Make a donation

Drug Access

In recent years, patients are living longer thanks to the discovery and approval of newer treatments. Historically, treatment options for myeloma patients were limited to traditional chemotherapy, radiation, and/or high-dose chemotherapy, also known as an autologous stem cell transplant. Over the past 15 years, treatment options have increased significantly with the addition of novel, targeted agents.

Click on the links below to learn more about the drug approval and reimbursement process in Canada, as well as how we advocate for the myeloma patient community.

Drug coverage in Canada

Myeloma Drug Access Navigator 

Drug approval updates

Advocacy in Canada